The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
Heparin, also known as unfractionated heparin (UFH), is a medication and naturally occurring glycosaminoglycan. Heparin acts as an anticoagulant and is used for conditions such as acute coronary syndrome, atrial fibrillation (AF), venous thromboembolism (VTE), cardiop... Read more
Alopecia is a condition of partial or complete hair loss in an individual. Alopecia may begin with hair loss on the scalp, either in patches or on the entire head. The onset of this disease is often random, sudden, and recurrent. A... Read more
The demand for generic products is high in the pharmaceutical market in Latin America. Moreover, majority of pharmaceutical companies are gradually outsourcing manufacturing activities to contract manufacturing organizations (CMO). ... Read more
Facial care products such as cleansers are used to get rid of bacteria, dirt and pollutants from the skin. Serums contain antioxidants and anti-aging ingredients such as retinols and peptides, which stimulate collagen production. ... Read more
Radiodermatitis, also known as x-ray dermatitis, radiation dermatitis, radiation-induced skin reactions, or radiation injury, is a side effect of external beam ionizing radiation. Radiotherapy, used in the treatment of cancer or other diseases, is a major cause of rad... Read more
Poultry pharmaceuticals comprise vaccines, feed additive medication, and drugs such as parasiticides, and specialized products used to manage reproductive, metabolic or infectious diseases. The global poultry pharmaceuticals market... Read more
Technetium-99m is a short-lived form of Technetium-99, an isotope of technetium. It is found as a component of nuclear waste and is used as a medical diagnostic tool. It is used as a radioactive tracer and can be detected in the body by medical equipment such as gamma... Read more
General medicine, also known as internal medicine, is a specialty branch of medicine that deals with prevention, diagnosis, and treatment of internal diseases. The training and career pathways in general medicine vary worldwide. In the U.S., general medicine can be pu... Read more
Diabetes is characterized by high presence of blood glucose, also called blood sugar, in the body. There are three main types of diabetes: type 1, type 2, and gestational diabetes. Oral glucose tolerance testing and hemoglobin A1c (HbA1c) testing are some of the tests... Read more
Anastrozole is a medication used for treatment of breast cancer. It is specifically used for hormone receptor-positive breast cancer. It has also been used to prevent breast cancer in those women who are at high risk of menopause. Anastrozole belongs to the aromatase-... Read more
Meperidine belongs to a class of drugs known as opioids, and is an analgesic similar to morphine. Meperidine was originally approved in 1942. Meperidine is available in different dosage forms such as tablets, syrup, oral solution, and injectable solutions. Meperidine ... Read more
Liver represents the largest organ of the body performing a wide variety of roles that include converting food into energy, creating bile for proper digestion of food, and detoxifying alcohol and poisons from the blood. There are several kinds of liver diseases such a... Read more
Antioxidants such as Lutein and Zeaxanthin of the carotenoid family are some of the eye health supplements. Lutein and Zeaxanthin are two types of carotenoids found in green leafy vegetables and other plants. These supplements protect eyes from harmful high energy wav... Read more
Human immunoglobulin is a sterile solution made from human plasma. Diseases such as primary immunodeficiency are treated by administering human immunoglobulin through intravenous injection (IGIV). Human immunoglobulin also helps in increasing the platelets (blood clot... Read more
The pharmaceutical and medical device sectors are slowly transitioning from an integrated process model to an outsourcing model where companies in these sectors outsource various processes such as clinical trials, medical writing, and regulatory processes to contract ... Read more
Androgen Replacement Therapy or low testosterone therapy is commonly called hormone replacement therapy for men. It is designed to counteract the effects of reduced activity in the gonads or hypogonadism. Hypogonadism in men is a clinical syndrome which results in the... Read more
Antiparasitic drugs such as anthelmintics, antiporozoals, and others agents are used in the treatment of the parasitic infectious diseases. According WHO estimation in March 2020, parasitic disease affects 1.5 billion people globally. These diseases include gast... Read more
Hydroxychloroquine is a safer derivative of chloroquine. Hydroxychloroquine is an immunosuppressive and anti-parasite drug indicated for the treatment or prevention of malaria, although the drug is ineffective for chloroquine-resistant malaria. Hydroxychloroquine is a... Read more